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ABSTRACT

Placenta-specific 1 (Plac1) is an X-linked gene that is essential for normal placental
development. Previous studies have shown that Plac1 is also expressed in the fetal brain and
paternally imprinted. Its expression in the fetal brain is markedly downregulated immediately
after birth. Plac1 ablation predisposes Plac1-null males and Xm-X Hets (inactive maternal allele)
to an increased risk of developing lethal postnatal hydrocephalus suggesting a functional role for
Plac1 during embryonic development. The objective of this study was to characterize the effect
of Plac1 on brain development and postnatal function. In order to address this, a mutant Plac1
mouse model, established on the C57BL/6J background, was studied. Formalin-fixed, paraffinembedded whole mount embryos and brain sections were obtained at various stages of
development. Plac1 expression was assessed by qRT-PCR and immunohistochemistry (IHC).
Brain structure was assessed by histopathological and magnetic resonance imaging (MRI)
analysis. Behavioral analysis was conducted using the PhenoMaster automated cage system and
a battery of classical behavioral tests. Our results revealed Plac1 expression throughout the
embryonic brain when assessed by qRT-PCR and IHC at E16.5 and E18.5. MRI analysis of an
adult Plac1 knockout (KO) brain revealed microcephaly (14%), reduced ventricular volume, and
increased heterogeneity of the medulla compared to a WT brain. Consistent with these findings,
H&E staining of the KO brain revealed a smaller cortical mantle, a dysmorphic hippocampus,
and a dysmorphic cerebellum with reduced folia. IHC analyses of NF-M, NeuN, and Iba1
immunostaining revealed significant reductions in axonal and neuronal development and
v

increased activated microglia in KO brain, but not in Xm-X Hets. Although no structural
abnormalities were detected in Xm-X Hets, behavioral analyses did reveal reduced activity and
behaviors consistent with increased anxiety. In conclusion, Plac1 is a paternally imprinted, Xlinked gene that is associated with abnormal brain development, reduced activity, and specific
behavioral abnormalities.
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CHAPTER ONE:
INTRODUCTION

The PLAC1/Plac1 Gene
Placenta-specific 1 (PLAC1) is an X-linked gene that was originally believed to be
expressed solely in the placenta. Northern blot analysis and in situ hybridization at the time
suggested PLAC1 expression was restricted to placental trophoblasts during development
(Cocchia et al., 2000; Fant et al., 2002). Expression of murine Plac1 is highest in the placenta
from embryonic days 7.5-14.5 (E7.5-E14.5). Expression was reported to be restricted to
trophoblast-derived cells, including cells in the spongiotrophoblast, placental labyrinth, and
trophoblast giant cells. In humans, PLAC1 expression remains relatively constant from 22 to 40
weeks of development (Fant et al., 2002; Massabbal et al., 2005). Recent research has elucidated
a more complicated expression profile where its expression was shown to occur throughout the
entire embryo, in particular, the brain, heart, kidney, and lungs (Jackman, Kong, & Fant, 2012;
Kong, Jackman, & Fant, 2013). Interestingly, expression has also been detected in a wide range
of tumors and transformed cell lines (J. Chen et al., 2006; Koslowski et al., 2007; Silva et al.,
2007). Placental tumor choriocarcinoma cell lines BeWo, JAR, and JEG, neuroblastoma cell line
LA1-56, and a number of others had significant PLAC1 expression. PLAC1 was also expressed
in approximately 82% of primary breast tumors and 50% of gastric tumors.
PLAC1 maps to Xq26, 65 kilobases telomeric to the gene hypoxanthine-guanine
phosphoribosyltransferase, which codes a protein important in purine metabolism (Cocchia et al.,
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2000). This area of the X chromosome is considered important for fetal development. Large
deletions (200-700 kb) around the Hprt locus in several mice resulted in a runty phenotype or
death (Kushi et al., 1998). Also, this region has been implicated in interspecific hybrid viability
(Zechner et al., 1996). The deletion of the Hprt gene itself does not result in abnormal placental
phenotype in mice, suggesting that some gene(s) nearby, such as PLAC1, may be responsible
(Searle, Edwards, & Hall, 1994).
PLAC1 has six exons, with the last exon coding for the protein (Y. Chen, Moradin,
Schlessinger, & Nagaraja, 2011). PLAC1 contains two active promoters, P1 and P2. P1 lies
upstream of the first exon, while P2 lies just upstream of exon 4. This unique structure is
conserved in mouse Plac1. Nuclear receptors retinoid X receptor alpha (RXRα) and liver X
receptor (LXR) activate both promoters, and putative RXRα binding sites have been detected on
P1. Both receptors are expressed prominently in the placenta during development. RXRα is the
dominant isoform in placenta, and selective knockout is associated with several severe placental
defects and potential embryolethality (Sapin, Dolle, Hindelang, Kastner, & Chambon, 1997). In
normal placenta, P2 is the primary promoter. However, in studied cancerous cell lines, the
preferred promoter is variable (Y. Chen et al., 2011). The significance of the different PLAC1
isoforms is unknown.

The PLAC1/Plac1 Protein
The putative PLAC1 protein is relatively small. The human open reading frame (ORF)
encodes a protein of 212 amino acids; the mouse Plac1 protein is 173 amino acids but very
homologous to human – 75% similar at the DNA level and 60% at the amino acid level (Cocchia
et al., 2000). The amino acid sequence contains a signal peptide, suggesting that PLAC1 is likely
2

targeted to the secretory pathway and exists as an extracellular protein. Interestingly, both
proteins share sequence homology with zona pellucida 3 protein, a specific sperm-binding
protein in the zona pellucida critical for fertilization. This zona pellucida domain (ZPD) has been
found and characterized in other secreted glycoproteins, such as uromodulin and betaglycan
(Bork & Sander, 1992; Jovine, Qi, Williams, Litscher, & Wassarman, 2002). In particular, this
domain is used for cross-linking and polymerization along the sequence, suggesting that PLAC1
may also possess such an attribute. The presence of the ZPD, alongside immunohistochemical
localization studies, suggest that PLAC1 is a secreted or membrane-bound protein. Furthermore,
the lack of cytoplasmic signaling domains in PLAC1 suggests that the protein likely modulates
signaling transduction pathways mediated by other receptors (Fant, Farina, Nagaraja, &
Schlessinger, 2010).
PLAC1 also appears to elicit an antibody response. Some patients with high-PLAC1
expressing cancers were found to have developed circulating anti-PLAC1 antibodies. In a study
of patients with colorectal cancer, approximately 50% of tumor samples expressed detectable
PLAC1 mRNA (Liu et al., 2008). Of patients with these tumors, more than half expressed
responsive T cells, and about 30% expressed spontaneous auto-antibodies against PLAC1. In a
study of patients with hepatocellular cancer, 32% of samples expressed PLAC1, and 4% of all
patients were seropositive for PLAC1 antibodies (Dong et al., 2008). Preliminary analysis of the
patients of both studies suggested that the presence of these PLAC1 auto-antibodies provided a
significant survival advantage. These data suggest not only that PLAC1 has some distinctive role
in cancer biology, but also that targeting the PLAC1 antigen may be a viable therapeutic
strategy. Indeed, PLAC1 silencing and PLAC1 neutralization by antibodies in MCF-7 breast
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cancer cells resulted in decreased motility, invasiveness, and cell proliferation (Koslowski et al.,
2007).

PLAC1 Function
The mechanism of action for PLAC1 is unknown. The prior discussion on the putative
sequence of the PLAC1 protein and experiments exploring the relationship of PLAC1 in various
cancers suggests that the protein plays some role in migration and invasion of placental
processes. The interactive ZPD and lack of cytoplasmic signaling domains suggests modulation
of other signaling protein pathways. Differential microarray analysis of E18.5 KO placentae
revealed downregulation of several genes important in embryogenesis, including Bmp, Wnt, and
Pdgf (Fant, unpublished data). Canonical pathways implicated include “ES Cell Pluripotency”,
“Integrin Signaling”, “Glioblastoma Multiform Signaling”, and “Axonal Guidance Signaling”.
PLAC1 is required for normal placental development. Intensive study of a mutant mouse
model in our laboratory demonstrated that ablation of Plac1 resulted in significant
placentomegaly (100% increase) and intrauterine growth retardation (IUGR) (Jackman et al.,
2012). The effect was most pronounced in male Plac1 knockouts (KOs), followed by Xm-X Hets
(inactive maternal allele). No female KOs were identified postnatally. While examining the
postnatal phenotype of mutant Plac1 mice, a number of interesting and important observations
were made. First, KO males exhibited decreased postnatal viability. Approximately 20-25% of
the expected number of KO males survived. Second, and more surprisingly, although some
surviving KO males appeared normal and were fertile, 22% developed lethal hydrocephalus
(HC) at 4-8 weeks of life (Kong et al., 2013). Third, although the Xm-X heterozygotes exhibited
normal postnatal viability they also exhibited an increased risk (11%) of developing lethal
4

hydrocephalus at 4-8 weeks of age. These observations strongly suggested a functional role for
brain-derived Plac1 in brain development and function.
In the work described in this thesis, we further examined Plac1 expression in the brain
during development. We show that Plac1 KO mice exhibit a number of histological
abnormalities and structural malformations. Furthermore, we report that female Plac1 Hets (XmX) exhibit reduced activity likely related to anxiety using both automated cage observation and
specific behavioral testing.
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CHAPTER TWO:
METHODS

Plac1 Mutant Mouse Model
Mutant mice were bred against a C57/BL6 background as described previously (Jackman
et al., 2012). The Plac1 open reading frame on exon 6 was deleted in murine embryonic stem
(ES) cells by the Knockout Mouse Project (KOMP) VelociGene approach (KOMP-NIH
initiative; http://www.velocigene.com/komp/detail/10766). Blastocysts were injected with Plac1null ES cells to produce chimeras (KOMP). Mice were bred against C57BL/6 background once
germline transmission was established. Procedures and protocols such as timed mice matings
were carried out in accordance with Institutional Animal Care and Use Committee (IACUC) of
the University of South Florida College of Medicine Protocol Number R4228 (Appendix A).

Genotyping Determination for Mice
Genotyping was performed using PCR as described elsewhere (Kong et al., 2013). DNA
was isolated from embryonic mouse tails using a DNeasy Blood and Tissue Kit (Qiagen,
Valencia, CA). Plac1 genotype was determined by PCR, using the following primers: 50CCAATCATGTTCACCCACATTTCTAC (WT forward);
50-CCCTAAAAGAGCTATCATGGCATCT (reverse);
50-GCAGCCTCTGTTCCACATACACTTCA (neomycin universal forward). The cycling
parameters were: 94°C for 5 min, followed by 10 cycles of 94°C for 15 sec, 65°C for 30 sec
6

(decreased by 1°C at each repeat), and 72°C for 40 sec; followed by 30 cycles of 94°C for 15
sec, 55°C for 30 sec, and 72°C for 40 sec. PCR products were terminated with a final extension
at 72°C for 5 min, then held at 4°C. A 1% agarose gel was used to visualize the generated
wildtype and mutant bands at 548 and 326 bp, respectively.

Quantitative Measurement of Brain Plac1 mRNA
WT pregnant females were euthanized at E16.5 and E18.5 during gestation and the brains
collected. Specific regions of each embryo’s brain were dissected under a dissecting microscope,
placed in RNAlater (Qiagen, Valencia, CA), and pooled with the same region collected from the
other littermates. Total RNA was then prepared using the AllPrep DNA/RNA Kit (Qiagen).
Plac1 mRNA was measured by qRT-PCR and normalized against 18S ribosomal RNA as
described in Kong et al. 2013 (Kong et al., 2013). The brain regions (cerebellum, medulla, pons,
etc.) pooled from embryos derived from one litter constituted 1 sample. The average expression
for each region was determined from at least 2 litters.

Hemotoxylin and Eosin (H&E) Staining
H&E staining was performed by the Moffitt Tissue Core (http://moffitt.org/research-clinical-trials/research-cores--technology/tissue-core) using a standard protocol.

MRI Analysis
Mice underwent a T2-weighted MRI. Regions of interest, in particular the ventricles,
medulla, and hippocampus, were drawn and compared using the Aedes software package
(Aedes, Finland, http://aedes.uef.fi/).
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Immunohistochemistry
Paraffin embedded tissue were cut into 5 uM sections onto glass slides. The slides were
deparaffinized in xylene (Thermo Fisher Scientific, Waltham, MA) for 2x10 min, rehydrated in
100% EtOH for 2x5 min, 95% EtOH for 5 min, 75% EtOH for 5 min, 50% EtOH for 5 min, and
finally in dH2O for 5 min. The slides were washed in Phosphate buffered saline (PBS) for 10
min. and excess liquid drained. The slides were washed with PBT (PBS + 0.1% Tween-20) for
3x5 min, and then incubated in blocking buffer (10% serum of secondary antibody host serum in
PBT) for 1 hour at room temperature. The slides were then incubated in primary antibody in
blocking buffer overnight at 4°C. Non-specific staining was determined by incubating with
homologous non-immune serum (dilution equivalent to primary antibody). The slides were then
washed in PBT 3x5 min. and incubated with IgG from primary antibody host (VectaStain Elite
ABC kit, Vector Labs, Burlingham, CA) for 1 hour. The slides were placed in ABC reagent (per
protocol) for 30 min and washed in PBT 3x5min, stained using diaminobenzidine substrate, then
mounted. Primary antibodies and dilutions used include anti-Plac1 (Abbomax, San Jose, CA,
1:200 dilution), anti-NF-M (Santa Cruz Biotechnology, Dallas, TX, 1:50 dilution), anti-NeuN
(Millipore, Billerica, MA, 1:125 dilution), and anti-Iba1 (Wako Pure Chemical Industries,
Osaka, Japan, 1:333 dilution).

Image Analysis
Immunohistochemical pictures were quantitatively analyzed using ImageJ v1.46r
software (NIH, http://imagej.nih.gov/ij/download.html). Color threshold RGB values were
obtained manually, then applied systematically to each sample using built-in function “Analyze

8

Particles” to obtain area percent stain or number of cell bodies. Parameters were chosen
appropriately to accurately capture cell bodies or positive staining regions.

PhenoMaster Analysis
The PhenoMaster system (TSE Systems GmbH, Bad Homburg, Germany) is a modular
automated high-throughput home-cage environment capable of recording physiological and
behavioral data with high spatial and temporal resolution (Clemens, Jansson, Portal, Riess, &
Nguyen, 2014; Urbach et al., 2014). The setup used for these studies allowed simultaneous
observation of 12 mice. The experimental window consisted of 5 days. The 5 day observation
period was split into two time frames – the first 24 hours of monitoring, or “Day 1”, and the
remaining 96 hours, or “After Day 1”. This was done to separate the acclimation or exploration
period from the period of normal activity. There was further stratification by light, dark, and both
cycles. Raw data was compressed within the PhenoMaster software. Data was extracted and
analyzed using Microsoft Excel.

Specific Behavioral Testing
Mice were also subjected to a battery of well-described rodent behavioral tests, including
the Elevated Plus Maze (EPM), Open Field Test (OF), Y-maze, Novel Object Recognition Test
(NOR), Rotarod, and Radial Arm Water Maze (RAWM).

Elevated Plus Maze
The EPM was employed to evaluate anxiety as described elsewhere (Arendash et al.,
2001). The maze consisted of four arms (30 x 5cm) connected by a central area (5 x 5cm), all
9

constructed of plywood and painted black. Two opposite-facing arms were open, while the other
two were enclosed by aluminum sheet walls 15 cm high. The maze was elevated 82 cm above
floor level. One mice at a time was placed in the central area, and its movement was recorded by
ceiling video camera during a single 5 minute trial. The data was analyzed using video tracking
software ANY-maze (ANY-maze, Stoelting, IL). Between mice, the maze was cleaned using
70% ethanol to minimize olfactory cues.

Open Field Test
Animals were monitored for 15 minutes in a 40 cm square open field with video tracking
software (ANY-maze, Stoelting, IL), under moderate lighting as a standard test of general
activity.

Y-maze
Each animal was placed in a walled Y-maze and allowed to roam freely for a single 5
minute trial. The sequence of arm entries and total number of arm choices were recorded.
Spontaneous alternation, or the proportion of arm selections made consecutively without
repetition, was calculated and expressed as a percentage (Anisman, 1975).

Novel Object Recognition Test
Described elsewhere (Brownlow et al., 2014). The test consists of a 40 x 40 cm area
monitored by video tracking (ANY-maze, Stoelting, IL). Two objects similar in scale to the
mouse were placed along the center line of the arena approximately 3-5 cm from the outside
wall. Each animal was given three acclimation trials of 5 minutes each with 5 minutes in
10

between. After each trial, the arena and object cues were cleaned with 70% ethanol to minimize
olfactory cues. Five minutes after the final acclimation trial, one of the objects was replaced by a
novel object. The mice were then observed by video tracking over a 5 minute exploratory trial.
Working memory was assessed by the exploration index, defined as the time spent exploring the
novel object over total exploration time.

Rotarod
Described elsewhere (Morgan et al., 2008). Mice were placed onto the round portion of a
motorized circular rod (Ugo Basile Rota-rod model 7750). Mice were required to walk at the
speed of rod rotation to prevent falling. The rod slowly accelerated every 30 seconds from 2.5
RPM to 34 RPM over 5 minutes. Time until falling was recorded for each mouse. Mice were
given three trials each day, separated by at least ten minutes, for 5 consecutive days. The average
time until falling for each day was recorded. The maximum possible time on the rod is 300
seconds, which is rarely met.

Radial Arm Water Maze
The test contained six swim arms radiating from an open central area, with a submerged
hidden escape platform located at the end of one of the arms. Starting with a randomly selected
arm, the mice were placed at the end of an arm and was allowed to swim in the maze for up to 60
seconds to find the escape platform. The escape platform was located in the same arm each trial.
On day one, mice were given 15 trials (three per block) alternating between a visible platform
(above the water) and a hidden one (below the water). The following day, they were given 15
trials with every trial using a hidden platform. The start arm was varied for each trial to
11

emphasize mice learning by spatial cues rather than motor learning. Entry of all four limbs in an
incorrect arm or failure to enter the correct arm within 20 seconds was scored as an error. Errors
for the three trial blocks were averaged for data analysis. On the third day, a reversal experiment
was performed with the goal placed in the arm opposite (180°) from the original location. Mice
were given 15 trials to unlearn the first location and find the second location through training. On
the fourth day, the arms were removed, the platform was raised above the water, and a flag was
attached to the platform to confirm all mice were capable of seeing and climbing onto the
platform (open pool). The time taken to reach the platform was recorded.

Statistical Analysis
Data obtained from ImageJ stain analyses were compared using Student’s T test.
Variables obtained from PhenoMaster analysis were stratified by age, experimental phase, and
day status (ie. light, dark), and compared using Student’s T-test. Variables recorded from the
remaining specific behavioral tests were compared using Student’s T-test. Comparison of
variables along time were analyzed using repeated measures ANOVA. An alpha of 0.05 was
applied for all tests performed.
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CHAPTER THREE:
RESULTS

PLAC1 is Expressed Throughout the Fetal Brain
In order to establish the pattern of Plac1 expression during fetal development, Plac1
mRNA was measured in various regions of the brain using quantitative real-time PCR (qRTPCR). Brains were obtained from WT embryos at E16.5 and E18.5 (n = 2 litters) and divided
into distinct anatomical regions. Total RNA was subsequently obtained and quantified. Plac1
mRNA was detected throughout the fetal brain especially the pons, midbrain, cerebellum, and
hippocampus (Figure 1). These findings are consistent with previously reported data from our
laboratory that localized Plac1 mRNA to the periventricular cortex, pons/medulla, and
cerebellum by in situ hybridization (Kong et al., 2013).

Normalized Gene Relative
Expression Level (*106)

35
30
25
20
E16.5

15

E18.5

10
5
0
Hippocampus

Cortex

Cerebellum

Pons

Medulla

Striatum

Midbrain

Olfactory
bulb

Figure 1. Plac1 mRNA expression by anatomy in the mice brain at E16.5 and E18.5. n = 2 each.
Plac1 mRNA was obtained from respective areas of mice brain at appropriate developmental
stage. Individual samples were done in triplicate.
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Localization of Plac1 expression during development was further explored using
immunohistochemistry (IHC). Anti-Plac1 polyclonal antibodies were used to perform DABbrown immunostaining on whole-mount WT, Xm-X Hets, and KO embryos at E18.5 according to
protocol (Figure 2). In the WT embryo, Plac1 was detected throughout the brain, particularly in
the vomeronasal organ, the olfactory bulb, and the cerebral cortex. Plac1 expression in the Het
and KO were appreciably lower, verifying the specificity of the anti-Plac1 antibody used. These
findings are consistent with the qRT-PCR data, suggesting that Plac1 may have a general role in
brain development.

WT

Xm-X

OB
C

VM

KO

NC

Figure 2. Plac1 localization by Immunohistochemistry using anti-Plac1 antibody of E18.5
whole-mount embryos. OB – olfactory bulb, VM – vomeronasal organ, C – cerebral cortex.
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Ablation of Plac1 Results in Abnormal Brain Structure
In order to gain insight into possible neurological functions for Plac1 during brain
development, brains of postnatal mice of each genotype were obtained and compared using a
variety of relevant criteria. H&E staining of WT and KO mice revealed a number of striking
histological changes, including decreased size of lateral ventricles, disorganized neuronal
distribution, especially on the parietal cortex, and a simpler cerebellum with reduced folia
(Figure 3). These findings are consistent with prior MRI analysis of WT and KO brains, which
showed KO brains have 12% decreased overall brain volume and 14% decrease in ventricular
volume, adjusted for total brain volume (Figure 4). Furthermore, MRI revealed greater tissue
heterogeneity in the KO medulla compared to WT, indicating possible structural abnormalities in
the observed brain (See Tables 1 and 2).

KO (17 mo.)
A

WT (13 mo.)

B

D

C

E

F

Figure 3. H&E stain comparison of KO and WT mice brains. Significant alterations include
narrowed ventricles (A vs. D), abnormal cell organization with disorganized parietal cortex
layering (B vs. E), and truncated cerebellar folia (C vs. F).
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Figure 4. MRI visualization of KO and WT brains. KO brain (left, red) is visibly smaller than
WT brain (right, green). MRI image analysis results displayed in Tables 1 and 2.

Region of Interest

Relative Volume

Relative Normalized
Volume

Lateral Ventricles

0.8340898

0.962676

Third Ventricle

0.5471264

0.631473

Fourth Ventricle

0.4681529

0.540325

Total Ventricular Volume

0.7463397

0.861398

Brain

0.8664287

1

Table 1. MRI volumetric comparison of KO and WT brains. The KO brain is approximately
14% smaller than WT control. Furthermore, ventricular volume normalized to total brain smaller
is 14% smaller in KO than WT control.
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Region of Interest

Relative Mean CSF
Intensity

Relative St. Dev

Difference?

Lateral Ventricles

1

0.9889617

Very similar

Third Ventricle

0.91061255

0.91115869

similar

Fourth Ventricle

0.94020847

0.98043895

Very similar

Cerebellum

0.98558179

0.9490877

similar

Medulla

0.99962243

1.38080484

Different STD

Hippocampus

0.92353926

0.93530759

Very similar

Brain

0.92366099

0.98755128

Very similar

Table 2. MRI voxel intensity comparison of KO and WT brains. The standard deviation of voxel
intensity in the medulla is approximately 38% greater in the KO than WT control, indicating
significant tissue heterogeneity.
A Plac1 KO Mouse Exhibited Altered Expression of NeuN, NF-M, and Iba1, While Xm-X
Hets Appeared Unaffected
In order to characterize specific neurological disturbances Plac1 ablation may instigate
later in life, mouse brains of each genotype were obtained and compared using
immunohistochemistry of various markers. Specifically, anti-Neuronal Nuclei (NeuN) and antiNeurofilament-M (NF-M) were employed to assess potential neuronal and axonal damage. A KO
male brain exhibited significantly less NF-M expression than a male WT control, particularly in
the corpus callosum and caudate putamen (Figure 5). Analysis of anti-NeuN staining revealed
decreased staining and neuronal cell count in the cerebellum, hippocampus, and cortex (Figure
6). These data revealed that ablation of Plac1 expression resulted in decreased expression of
NeuN and NF-M, and interfered with normal axonal guidance.
Furthermore, immunohistochemical staining against Iba1, a marker for activated
microglia, allowed assessment of potential inflammatory consequences of Plac1 ablation in the
postnatal nervous system. Anti-Iba1 staining revealed significantly more activated microglia
throughout the brain in KO and Hets compared to WT equivalent later in life (Figure 7).
17

N.C.

KO

WT-M
A

B

C

D

E

F

Figure 5. Comparison of NF-M expression between male WT (WT-M) and male Plac1 KO
mice. KO mice brain show reduced NF-M expression and decreased axonal migration. NF-M
reduction in the KO brain compared to WT-M is evident throughout the entire brain, especially
in the corpus callosum, caudate putamen, and pons-medulla (A-C). Axonal migration in the
caudate putamen is visually hindered in the KO brain (D-F).

Cerebellum

Cortex

Hippocampus

A

B

C

D

E

F

WT-M

KO

Figure 6. Comparison of NeuN expression between male WT (WT-M) and male Plac1 KO mice.
WT-M neuronal expression in the cortex, cerebellum, and hippocampus (A-C) visually
outweighs expression in the KO equivalent (D-F).
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WT-M

KO

Figure 7. Iba1 IHC comparison between male WT (WT-M) and male Plac1 KO mice. KO mice
brain show significantly more activated microglia than WT. Pattern exists throughout the brain,
but particularly in the cortex.

Chronically activated microglia are usually suggestive of neuronal damage and
neurodegenerative disorders (Dheen, Kaur, & Ling, 2007). Plac1 ablation thus may predispose
mice to increased neuronal loss later in life.
Interestingly, NeuN, NF-M, and Iba1 expression of Xm-X Hets seem largely unchanged
compared to female age-matched WT mice. At 11 months, there is no appreciable difference
between stains for any marker (Figure 8). This similarity is confirmed using quantitative analysis
done through ImageJ. It appears that the paternal allele has enough function to rescue Xm-X Hets
from histological neuronal and axonal abnormalities throughout adulthood.

Reduction of Plac1 Expression Affects Various Behavioral Parameters in Mice
In order to detect potential downstream behavioral and phenotypical changes associated
with reduction Plac1 during development, female WT (WT-F) and Xm-X Hets (HETs) at various
matched ages were analyzed in both automated cage environments and classical test apparatuses.
Mice were first continuously monitored using the TSE PhenoMaster system.
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Figure 8. Comparison of staining of female WT (WT-F) and Plac1 Xm-X heterozygotes (HET) at
11 months. WT-F and HETs stain similarly using NF-M (A vs. B). NeuN is similar at the
cerebellum (C vs. D), cortex (E vs. F), and hippocampus (G vs. H). Iba1 is similar throughout
the brain (I vs. J). Quantitative threshold analysis using ImageJ (n = 3 each) confirms visual
similarities (K-M).
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PhenoMaster
PhenoMaster analysis revealed a number of significant differences in activity and
mobility parameters between WT-F and HETs (Figure 9). During Day 1, HETs at 5 months (nWTF

= 4, nHET = 4) exhibit decreased fine beam breaks (p = 0.006), increased locomotive speed (p =

0.038), and increased time asleep in the dark phase (p = 0.014), and decreased time active
considering both phases (p = 0.049). Over the entire experimental period, HETs at 5 months
show noticeably increased rearing activity (p = 0.049). HETs at 12 months (nWT-F = 7, nHET = 4)
spend significantly more time in the periphery of the cage rather than the center in the light phase
of both Day 1 (p = 0.037) and After Day 1 (p = 0.039), and increased rearing during the dark
phase after Day 1 (p = 0.050). Interestingly, when observing the sleeping habits of HETs at 5
months, these mice slept much more during the Day 1 than After Day 1, when the opposite is
expected. There were no significant alterations in feed and drink habits, or metabolic parameters
along either experimental period or age group. Collectively, these findings show that reduced
Plac1 expression during development is associated chiefly with decreased overall activity during
the acclimation phase at 5 months, and increased exploration and rearings throughout the entire
experiment at 12 months.

Specific Behavioral Testing
WT-F and HETs were further analyzed using a variety of classical behavioral tests. In
order to assess mobility and behaviors associated with anxiety, the Elevated Plus Maze (EPM)
and Open Field (OF) test were employed. The Y-maze was used to assess spatial working
memory. The Novel Object Recognition (NOR) test provided a measure of cognition and
recognition memory. Motor coordination, balance, and motor learning were assessed using the
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Figure 9. PhenoMaster analysis and comparison of female WT (WT-F) and Plac1 Xm-X
heterozygotes (HET) at 5 months (n = 4 each) and 12 months (nWT-F = 7, nHET = 4). At 12
months, WT-F mice at 12 months spend significantly more time in the center in both the
acclimation phase (A) and during the Light phase in After Day 1 (B). HETs at 5 months are
asleep more often in the Dark phase of Day 1 (C) and display an abnormal sleep acclimation
between experimental phases (D). Rearing were more common in HETs at 5 months during the
Light phase overall (E) and HETs at 12 months during the Dark phase After Day 1 (F). Fine
movements were significantly reduced in HETs at 5 months during the Dark phase in the
acclimation phase (G). HETs at 5 months on Day 1 were also less active overall (H) yet faster
during the active phase (I). Data represents means ± SEM (**p < 0.05, ***p < 0.01)
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Rotarod. Finally, spatial working memory and spatial learning were compared between the two
groups using the Radial Arm Water Maze (RAWM).
The EPM revealed further differences between WT-F (nWT-F = 5) and HET (nHET = 3)
mice at 16 months (Figure 10). There were no appreciable differences between HETs and WT-F
mice with regard to most classical anxiety-related parameters, including percent time in open
arms (p = 0.254), percent time mobile in open arms (p = 0.277), and ratio distance traveled in
open arms (p = 0.285). However, none of the HETs explored the entirety of the open arms, as
shown by respective heat maps, and HET mice heads entered the open arm zone less frequently
(p = 0.034). Furthermore, there were substantial differences between genotypes with regard to
locomotor skills, including total distance traveled (p = 0.001) and time immobile (p = 0.007).

Figure 10. Elevated Plus Maze analysis of female WT (WT-F, 16 mo., nWT-F = 5) and Plac1 XmX heterozygotes (HETs, 16 mo., nHET = 3). HETs traveled significantly less and were much less
mobile than WT-F, and HET mice heads entered the open arm zone less frequently (A). HETs
traveled less and spent less time than WT-F in the Open Arms, but were not statistically different
(B). However, unlike the WT-F, HETs did not explore most of the open arms (C). Heat maps
represent group occupancy plot of mice center position. Data represents means ± SEM (**p <
0.05, ***p < 0.01, ****p < 0.005)
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Further behavioral testing found no additional significant differences between WT-F and
HETs. OF testing (nWT-F = 7, nHET = 4) found a small but insignificant reduction in total distance
traveled, both overall (p = 0.279) and by three minute intervals (p = 0.99). HETs were slightly
more immobile (p = 0.103) and slower (p = 0.284), but were identical in regards to propensity to
the center (p = 0.941), the chief measurement for anxiety (Figure 11). Y-maze analysis showed
no differences in arm entries (p = 0.640) or percent alternation (p = 0.191) between WT-F and
HETs (Figure 12ab). The NOR test (nWT-F = 7, nHET = 3) showed no differences in attention paid
to the novel object (p = 0.896) and only slight reduction in discrimination ratio (p = 0.627)
(Figure 12cd). Rotarod analysis (Figure 12e) showed no overt deficiencies between WT-F and
HETs in continual motor control and learning in day 1 of testing (p = 0.175) nor day 2 (p =
0.278). The RAWM (nWT-F = 6, nHET = 3) showed a very modest increase in entry errors for
HETs (p = 0.884). There was no difference in error improvement over time in neither day 1 (p =
0.860), nor day 2 (p = 0.070). Furthermore, reversal of the maze showed no learning impairment
over time (p = 0.573), and open pool testing confirmed no visual or motor impairments (Figure
13).
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Figure 11. Open field test comparison of 16 mo. female WT mice (WT-F, nWT-F = 7) and 16 mo.
Plac1 Xm-X heterozygotes (HETs, nHET = 4). Mice are placed into a novel box environment and
resultant activity is recorded. HETs travel only slightly less than WT-F (A), and are comparable
over time (B). HETs are slightly less mobile (C) and slightly slower (D) than WT-F, but these
observations are not statistically significant. HETs and WT-F are similar with regards to time
spent in the center of the field (E).

Figure 12. Y-maze, Novel Object Recognition, and Rotarod performance comparisons of female
WT mice (WT-F) and Plac1 Xm-X heterozygotes (HETs). Y-maze (nWT-F = 7, nHET = 4) revealed
no significant differences in total number of entries (A), or percent of entries where the mice
enters all three arms sequentially without revisiting a previously selected arm (percent
alternation, B). In Novel Object Recognition (nWT-F = 7, nHET = 3), analysis revealed no
significant change in percent time exploring the new object vs. the old (C) or ratio of time spent
attending to the new object over the duration of the test (determination ratio, D). Rotarod (nWT-F
= 7, nHET = 4) test showed no significant difference between genotypes with regard to time
before falling off or performance improvement (E).
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Figure 13. Radial Arm Water Maze (RAWM) test performance comparison of 16 mo. female
WT mice (WT-F, nWT-F = 6) and 16 mo. Plac1 Xm-X heterozygotes (HETs, nHET = 3). In the
RAWM, mice are placed into a pool with six arms, with an escape platform at the end of one
arm. After 15 trials, mice rest for one day. The subsequent day of testing begins with the exit in
the same location as the final trial of the first day. WT-F and HETs perform similarly with regard
to learning performance (A) and total errors (B). On the third day, the exit for each trial is
opposite (180°) of the original location. There was no apparent difference between genotypes
with regards to adapting to this reversal (C) or total errors during the reversal experiment (D).
On the fourth day, the arms are removed from the pool, the platform is elevated, and a large flag
is placed on the goal. Mice are tested in this fashion to ensure that the mice can see and are able
to climb onto the platform. There were no deficiencies for any mice (E).
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CHAPTER FOUR:
DISCUSSION

In this study, we find that Plac1 is expressed throughout the entire fetal brain during
embryogenesis. Ablation of Plac1 results in histopathological abnormalities, including stunted
hippocampal, cerebellar, and cortical growth, and reduced volume of the lateral ventricles.
Furthermore, KOs show reduced neuronal and axonal expression, and an increase in microglial
activation. Plac1 mutants have been previously shown to be at risk for lethal hydrocephalus
(HC), with an 11% and 22% increase in risk for Xm-X heterozygotes (HETs) and KOs
respectively (Kong et al., 2013). L1CAM, a neural adhesion glycoprotein, serves as the genetic
basis for most cases of X-linked HC (Jouet et al., 1993). L1CAM additionally has the capability
to interact with FGF receptors, similar glycoproteins such as such as phosphaglycan, and its
surrounding environment, to induce signaling cascades (Weller & Gartner, 2001). PLAC1 is a
putative glycoprotein containing a zona pellucida 3 motif (Cocchia et al., 2000), a module
important in protein-protein interactions and polymerization (Jovine et al., 2002). Although the
mechanism of PLAC1 action is unknown, we speculate that it may interact with L1CAMdependent developmental and regulatory pathways during embryogenesis.
Knowing that Plac1 ablation is associated with increased risk of fatal postnatal HC, we
were surprised to observe that the knockout mice studied displayed restricted lateral ventricles
compared to the WT control. X-linked HC is typically associated with enlargement of the lateral
ventricles (Dahme et al., 1997; Fransen et al., 1998). There are a couple explanations for this
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observation. First, there is considerable variability of observed phenotypes in genetic mouse
models of disease that is dependent on factors such as mouse strain, genetic background, and
environmental influences (Cohen et al., 1998; Dahme et al., 1997; Doetschman, 2009; Fransen et
al., 1998; Kenwrick, Jouet, & Donnai, 1996). Second, Plac1 KOs show considerably reduced
viability (Jackman et al., 2012). The studied KO may display a milder phenotype that allowed
this individual animal to avoid developing HC. The exact mechanism of how Plac1 influences
the development of X-linked HC remains to be elucidated.
We next attempted to determine if Plac1 ablation led to long-term phenotypic changes in
adult mice. Although there were insufficient numbers of male KOs to study, we speculated that
female HETs would likely be affected. The PhenoMaster system was used to begin
characterizing the Plac1 phenotype. It is an automated high-throughput phenotyping platform
that allows unobtrusive and low-stress observation and analysis of spontaneous behavior of
several mice simultaneously. Although it has been recently proven to be a reliable and sensitive
tool in behavioral analysis (Clemens et al., 2014; Urbach et al., 2014) extensive validation is still
needed (Tecott & Nestler, 2004; van der Staay & Steckler, 2001). An increase in the number of
screened mice over a greater range of ages could allow the use of multivariate models, such
Partial Least Squares Discriminant Analysis, to better describe an overall Plac1-deficient
phenotype and make greater use of the collected data.
Results from these studies revealed that HETs exhibited decreased activity and increased
rearing during the acclimation phase at 5 months, and increased exploration, peripheral
movement, and rearings throughout the entire experiment at 12 months, compared to female WT
(WT-F) equivalents. These results suggest potential motor, anxiety, and memory-related
deficiencies that we qualify by classical behavioral testing.
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The elevated plus maze (EPM) and open field test (OF) are established tests used to
assess state anxiety-related behavior in rodents (Hazim, Ramanathan, Parthasarathy, Muzaimi, &
Mansor, 2014; Uys, Stein, Daniels, & Harvey, 2003). The OF test relies on the conflict between
the exploration of novel environment and the fear of open spaces. The percentage of time spent
in the center is the primary assay for anxious behavior (Prut & Belzung, 2003). Likewise, the
EPM pits aversion to elevated open spaces against the innate tendency to explore. Percentage of
time and number of entries into the open arms is used to assess anxiety and performance of
anxiolytics (Lister, 1987; Uys et al., 2003). We show that while HETs perform identically to
WT-F in the OF test, HETs have reduced head entries into open arms, do not explore the entirety
of the open arms, exhibit reduced exploratory behavior, and spend more time immobile or
frozen. Anxious behavior as seen on the EPM has been associated with knockout of serotonin
transporter 5-HTT and serotonin receptor 1A (Holmes, Lit, Murphy, Gold, & Crawley, 2003;
Ramboz et al., 1998), and decrease in GABAA neurotransmission (Andolina, Maran, Viscomi, &
Puglisi-Allegra, 2014; Ishihara, Hiramatsu, Kameyama, & Nabeshima, 1993). This suggests
Plac1 may have a role in the development of serotinergic or GABAergic circuits.
The lack of genotype effect of Plac1 on anxiety-related statistics in the OF test may be
due to several reasons. First, the EPM is usually considered a more sensitive test of anxiety
(Ramos, 2008). Second, it has been shown that EPM and OF measure different aspects of
anxious behavior. The measures of stress response between these tests depended on distinct
factors, and conflicting test results between OF and EPM is encountered often in
pharmacological screening (Anchan, Clark, Pollard, & Vasudevan, 2014; Ramos, 2008; Ramos,
Mellerin, Mormede, & Chaouloff, 1998; Vendruscolo, Takahashi, Bruske, & Ramos, 2003).
Third, the OF test may not encompass all measures of anxiety (Prut & Belzung, 2003). Multiple
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tests are often encouraged to gain a more comprehensive picture of rodent behavior (Ramos,
2008; van Gaalen & Steckler, 2000).
We show that HETs perform equivalently to WT-F on the Rotarod, suggesting
coordination, balance, and motor learning are largely unaffected in HETs. Cerebellar
performance, a key determinant of Rotarod results (Lalonde, Bensoula, & Filali, 1995), is
probably unaffected in HETs. The decrease in locomotor parameters seen in PhenoMaster
analysis and the EPM are likely related to exploratory or anxious behavior rather than an
inability to move. Furthermore, satisfactory performance on the radial arm water open maze
variant confirms that HETs have the ability to see and move properly. It would be interesting to
test KOs on the Rotarod, as there was observable dysmorphia and neuronal depletion in the
cerebellum of a Plac1 knockout that might hinder locomotion.
The Y-maze, novel object recognition (NOR), and radial arm water maze (RAWM) are
all useful behavioral assays for uncovering deficits in memory, locomotion, and cognition. The
Y-maze is typically employed as a measure of spatial working memory (Dridi et al., 2014). The
NOR task is sensitive for cognition and recognition memory deficits (Grayson et al., 2014). The
RAWM can be used to detect problems with spatial memory and learning (Alamed, Wilcock,
Diamond, Gordon, & Morgan, 2006; Shukitt-Hale, McEwen, Szprengiel, & Joseph, 2004). WTF and HETs performed similarly in all three tests, suggesting that HETs have no significant
deficits in spatial memory, learning, or cognition. These performances are classically linked to
hippocampal function (King, Trinkler, Hartley, Vargha-Khadem, & Burgess, 2004), implying
HET hippocampi are largely normal. However, recent review proposes that certain aspects of
anxiety are associated with the hippocampus (Bannerman et al., 2014). It is unclear how EPMrelated anxiety results and spatial memory performance correlate.
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Plac1 Xm-X heterozygotes appear to be spared from aforementioned gross anatomical
malformations, adulthood neuronal loss, reduced axonal development and migration, and
microglial activation. Although the paternal allele is largely silenced, the small amount of
residual expression that escapes inactivation appears to provide some degree of functional
compensation during development. This is consistent with the observed paternal imprinting of
Plac1 in maternal-allele Plac1 mutants (Jackman et al., 2012). However, the increased
susceptibility of HETs to HC, abnormal phenotypes of HET embryo and placenta (Jackman et
al., 2012), and reported distinct behavioral differences, strongly suggests there may be some
other manifestation of nervous system insult. Methods used for these studies may not have
detected subtle structural differences between HETs and WT-F brains. The comparison can be
expanded in several directions: incorporating more brain cell markers, such as astrocytes or
oligodendrocytes, using Weil stain to check for myelin, including a wider array of mice brain
ages, or analyzing certain neuronal circuits.
As the cellular function, location, and expression regulation of Plac1 expression have not
been fully characterized, it is impossible to highlight a causative role for Plac1 in the
development of the nervous system. It is possible the altered neural phenotype of Plac1 HETs
and KOs may result from aberrations in placental nutrient transport rather than direct action of
Plac1 in the developing brain. Recently, the placenta has been identified as an exclusive source
of serotonin for forebrain development between E10.5 and E15.5 of mouse development (Bonnin
et al., 2011). This is interesting given the association between Plac1 Xm-X heterozygotes and
possible serotonin-related anxiety. However, the small but detectable presence of Plac1 in the
embryonic brain suggests a more active role. Additionally, differential microarray analysis of
E18.5 KO placentae revealed downregulation of several genes important in embryogenesis,
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including Bmp, Wnt, and Pdgf (Fant, unpublished data). Heavily implicated affected canonical
systems include “ES Cell Pluripotency”, “Integrin Signaling”, “Glioblastoma Multiform
Signaling”, and “Axonal Guidance Signaling”, further suggesting a direct role for Plac1 in
neural development. Selective tissue knockouts for Plac1 can help examine the relative
importance of expression in these respective organs. Elucidation of PLAC1 function and
potential protein interactions will shed light into Plac1’s role in neural development.
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APPENDIX A:
IACUC APPROVAL DOCUMENTATION

Procedures and protocols such as timed matings between mice were carried out in
accordance with Institutional Animal Care and Use Committee (IACUC) of the University of
South Florida College of Medicine Protocol Number R4228. The following pages are scans of
IACUC approval documentation for the two years this study was conducted.
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